Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Healthcare Biotechnology
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is... see more

CSE:RVV - Post Discussion

Revive Therapeutics Ltd > Most likely the result of Covid-19 inflammation >>>
View:
Post by TheTerminator1 on Nov 18, 2021 5:44pm

Most likely the result of Covid-19 inflammation >>>

RVV's Bucillamine would have most likely prevented most of this aggravation

https://www.cnn.com/2021/11/18/health/covid-loss-of-smell-wellness/index.html
Comment by Trippedstocks on Nov 18, 2021 6:09pm
how would Bucillamine help with loss of smell?
Comment by TheTerminator1 on Nov 18, 2021 6:17pm
The short answer is Bucillamine keeps in the inflammtion in check....Covid-19 is all about inflammation!
Comment by Trippedstocks on Nov 18, 2021 8:09pm
So you think the inflammation induced in the sustentacular cells, from covid, causes cell damage and Bucillamine will prevent that damage? Or do you have information on how Bucillamine will bring back someone's smell after 9 months?
Comment by MyAli4s on Nov 23, 2021 8:42am
This post has been removed in accordance with Community Policy
Revive Therapeutics Ltd
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities